Inhaled powder could offer rapid migraine relief without needles
NCT ID NCT07646613
First seen Jun 27, 2026 · Last updated Jul 22, 2026 · Updated 2 times
Summary
This study tests an investigational inhaled medication called ASY202 (dihydroergotamine dry powder) for treating migraine attacks in adults. Participants use a handheld inhaler to take the drug or a placebo during separate migraine episodes, and neither they nor the study team know which is which. The goal is to see if ASY202 can stop headache pain and bothersome symptoms like light sensitivity or nausea within two hours. The trial involves about 108 people and lasts around 16 weeks.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- dihydroergotamine (DHE) inhaled dry powder
- What this could lead to
- If successful, this could provide a fast-acting, non-injectable option for treating migraine attacks at home.
- What could go wrong
- This is an early-phase trial with only 108 participants, so results may not apply to everyone. Inhaled DHE may cause side effects like throat irritation or nausea.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIGRAINE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Clinical Neuroscineces Solutions
NOT_YET_RECRUITINGOrlando, Florida, 32806, United States
Contact Email: •••••@•••••
-
Clinical Neuroscineces Solutions - Orlando
NOT_YET_RECRUITINGOrlando, Florida, 32801, United States
Contact Email: •••••@•••••
-
Clinical Research Associates, Inc.
NOT_YET_RECRUITINGNashville, Tennessee, 37203, United States
Contact Email: •••••@•••••
-
Highland Research
NOT_YET_RECRUITINGSalt Lake City, Utah, 84124, United States
Contact Email: •••••@•••••
-
M3 Wake Research - Las Vegas Rainbow
NOT_YET_RECRUITINGLas Vegas, Nevada, 89118, United States
Contact Email: •••••@•••••
-
Sunwise Clinical Research, Llc
RECRUITINGWalnut Creek, California, 94596, United States
Contact Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a numbing nose treatment stop migraine pain in its tracks?
- Can migraine meds be safe while breastfeeding? a new study investigates
- Could a symptom registry unmask hidden migraine variants?
- A migraine-blocking antibody tested in children as young as 6
- Mind over migraine: brain network may explain why some expect side effects
- The eyes as a window to the brain: can a simple scan monitor MS, Alzheimer's, and Parkinson's?